Tardio Jason 4
4 · Ovid Therapeutics Inc. · Filed Jul 1, 2021
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-01+50,000→ 50,000 totalExercise: $3.95Exp: 2031-06-30→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on July 1, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.